Baseline characteristics of patients with hypertrophic cardiomyopathy who developed heart failure
| All (n=218) | Mild (n=62) | Moderate (n=120) | Severe (n=36) | |
| Age, years | 63.3±14.5 | 58.6±13.5 | 64.3±14.5 | 67.8±14.4 |
| Female, n (%) | 92 (42.2) | 13 (21.0) | 51 (42.5) | 28 (77.8) |
| NYHA functional class, I/II/III/IV, n | 92/90/35/1 | 62/0/0/0 | 30/90/0/0 | 0/0/35/1 |
| NT-proBNP, pg/mL, median (Q1, Q3) | 409.5 (127.2, 992.5) | 93.0 (43.2, 191.5) | 662.0 (287.8, 1292.0) | 852.5 (521.0, 1897.0) |
| KCCQ-12, median (Q1, Q3) | 87.5 (65.5, 96.9) | 96.9 (90.6, 100.0) | 82.3 (65.3, 94.8) | 64.0 (50.2, 83.8) |
| Type | ||||
| HNCM, n (%) | 137 (62.8) | 53 (85.5) | 75 (62.5) | 9 (25.0) |
| HOCM, n (%) | 81 (37.2) | 9 (14.5) | 45 (37.5) | 27 (75.0) |
Data are presented as mean±SD unless otherwise indicated.
HNCM, hypertrophic non-obstructive cardiomyopathy; HOCM, hypertrophic obstructive cardiomyopathy; KCCQ-12, Kansas City Cardiomyopathy Questionnaire-12; NT-proBNP, N-terminal prohormone of brain natriuretic peptide; NYHA, New York Heart Association.